Cytochalasins from an endophytic fungus Phoma multirostrata XJ-2-1 with cell cycle arrest and TRAIL-resistance-overcoming activities
[Display omitted] •Nine new [13]cytochalasins were identified from Phoma multirostrata XJ-2-1.•Compound 6 displayed moderate cytotoxicity against CT26 and A549 cell lines.•Compound 6 could induce cell cycle arrest at G2-phase and cause cell shrinkages.•Compounds 7–9, 13 and 16 showed TRAIL-resistanc...
Gespeichert in:
Veröffentlicht in: | Bioorganic chemistry 2020-11, Vol.104, p.104317, Article 104317 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•Nine new [13]cytochalasins were identified from Phoma multirostrata XJ-2-1.•Compound 6 displayed moderate cytotoxicity against CT26 and A549 cell lines.•Compound 6 could induce cell cycle arrest at G2-phase and cause cell shrinkages.•Compounds 7–9, 13 and 16 showed TRAIL-resistance-overcoming activity in A549 cells.
Nine new (1–9) and four known (10–13) [13]cytochalasins, along with three known 24-oxa[14]cytochalasins (14–16), were isolated from the culture of Phoma multirostrata XJ-2-1, an endophytic fungus obtained from the fibrous root of Parasenecio albus. Their structures were elucidated by interpretation of the nuclear magnetic resonance (NMR) and high-resolution electrospray ionization mass spectroscopy (HRESIMS). The absolute configurations were assigned by single-crystal X-ray crystallography, modified Mosher′s method, and by analysis of their experimental electronic circular dichroism (ECD) spectra. Compound 6 could induce cell cycle arrest at G2-phase in CT26 and A549 cells, and displayed moderate cytotoxicity against CT26 and A549 cell lines with IC50 values of 6.03 and 5.04 μM, respectively. Co-treatment of 7–9, 13 and 16 with tumor necrosis factor related apoptosis inducing ligand (TRAIL) could significantly decrease the cell viability of A549, which revealed that cytochalasins could possibly be a new group of TRAIL sensitizers in lung cancer therapy. |
---|---|
ISSN: | 0045-2068 1090-2120 |
DOI: | 10.1016/j.bioorg.2020.104317 |